Kezar Life Sciences, Inc. (KZR)

7.29 0.00 (0.00%) USD  |  NASDAQ  |  Aug 28, 16:00
More

Kezar Life Sciences Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for KZR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2023. Start Trial.
Date Value
May 11, 2026 --
March 30, 2026 --
February 20, 2026 --
November 13, 2025 --
September 24, 2025 --
August 14, 2025 --
July 16, 2025 --
June 27, 2025 --
May 14, 2025 --
May 13, 2025 --
March 25, 2025 --
February 28, 2025 --
February 25, 2025 --
February 21, 2025 --
February 18, 2025 --
Date Value
December 19, 2024 --
December 02, 2024 --
November 13, 2024 --
October 18, 2024 --
October 17, 2024 --
October 02, 2024 --
August 15, 2024 --
August 14, 2024 --
August 13, 2024 --
April 04, 2024 --
March 15, 2024 --
February 23, 2024 --
November 27, 2023 --
November 14, 2023 --
October 04, 2023 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
NovelStem International Corp. Upgrade
Brainstorm Cell Therapeutics, Inc. Upgrade
Summit Therapeutics, Inc. Upgrade
Protara Therapeutics, Inc. Upgrade
Clene, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade